Remdesivir: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "==Background== * Direct antiviral * Indicated for SARS-CoV-2 and possibly Ebolavirus infections ==Dosing== ===COVID-19=== * Early treatment of mild disease patients at high risk of progression (within 7 days of onset): 200 mg IV on day 1 followed by 100 mg IV daily for 2 days * Treatment of moderate disease newly on low-flow oxygen: 200 mg IV on day 1 followed by 100 mg IV daily for 4 days Category:Antivirals" |
(No difference)
|
Latest revision as of 14:15, 27 October 2022
Background
- Direct antiviral
- Indicated for SARS-CoV-2 and possibly Ebolavirus infections
Dosing
COVID-19
- Early treatment of mild disease patients at high risk of progression (within 7 days of onset): 200 mg IV on day 1 followed by 100 mg IV daily for 2 days
- Treatment of moderate disease newly on low-flow oxygen: 200 mg IV on day 1 followed by 100 mg IV daily for 4 days
